Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Sigilon

<< Previous

Bullboard Posts

Next >>

Post by BioTeckon Dec 09, 2020 5:52pm

310 Views

Post# 32073225

Sigilon

Sigilon Therapeutics went public today and is trading at $28.00. Adjusted for our surplus of outstanding shares (thanks management), we should be well over $2 considering we have everything they have and more.

Does management have what it takes to get SVA to fair value? It's now or never.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"